Mark Findeis

Mark Findeis

Company: Agenus Bio

Job title: Executive Director, Research Biochemistry


Next Generation Cancer Vaccine-Adjuvant Combinations 12:30 pm

• Heat shock protein as neoantigen peptide chaperone • High-yield synthesis of neoantigen peptides • New adjuvant manufacturing and formulations to combine with vaccinesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.